Original paper

The development of therapeutic cancer vaccine for pancreatic cancer.

Volume: 38, Issue: 4_suppl, Pages: 707 - 707
Published: Feb 1, 2020
Abstract
707 Background: A previous phase II/III trial using a single cancer peptide vaccine derived from vascular endothelial growth factor receptor (VEGFR)2 for patients with advanced pancreatic cancer did not demonstrate the overall survival (OS) benefit (Yamaue et al. Cancer Sci 2015). However, for the next trial, we conducted a multicenter phase II study using multipeptide cocktail vaccine named OCV-C01 derived from a novel higher immunogenic...
Paper Details
Title
The development of therapeutic cancer vaccine for pancreatic cancer.
Published Date
Feb 1, 2020
Volume
38
Issue
4_suppl
Pages
707 - 707
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.